Thank you for your concern.
And that is why you need to be able to derisk the company when study results are impending.
If you check out the NTI threads I have done a lot of research and presented it derisking NTI.
In regards to NUH - someone wrote NUH has been hitting its milestones. And that is nice but as I have noted continually; NUH is not being priced on development based milestones anymore. Receipts are what will control NUHs price and I have seen little in regards to projection of sales or expectations from the company. This means NUH's receipts, outflows and balance become even more important.
If NUH pull out a big 4C then great. But stop falling for NUH's continual development stage milestone deflections like the one today. They are mere distractions to what matters to NUH right now.
Ann: Nuheara Commences Shipping of Next Generation IQbuds BOOST, page-36
Add to My Watchlist
What is My Watchlist?
